Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BioSante says tests for female sex drug positive
Yahoo/AP
Sunday, February 13, 2011 - 10:52am
tags:
BioSante, LibiGel, female sexual dysfunction
Soliris Continues to Drive Growth as Alexion Adds to Its Pipeline
Morningstar
Saturday, February 12, 2011 - 2:42pm
tags:
PNH, Soliris, Alexion
Emerging mkts to revive, boost global pharma industry
MoneyControl
Saturday, February 12, 2011 - 2:40pm
tags:
emerging markets
Valeant's subsidiary Biovail acquires Canadian rights to Cholestagel from Genzyme
pharmabiz
Saturday, February 12, 2011 - 2:26pm
tags:
Biovail, Genzyme, Cholestagel, hypercholesterolemia, colesevelam
Bionovo Announces 2011 Plan of Action on MF101 (Menerb)
Bradenton Hareld, FL
Saturday, February 12, 2011 - 2:24pm
tags:
Menerba, MF101, Bionovo, hot flashes
Pronova BioPharma ASA (NO) - Building a base for sustainable growth
PharmaLive
Saturday, February 12, 2011 - 2:20pm
tags:
Pronova BioPharma ASA
Recent 52-Week High Exceeded in Shares of KV Pharmaceutical
Benzinga
Saturday, February 12, 2011 - 1:02pm
tags:
KV Pharmaceutical
AcelRx Pharmaceuticals raises $40 million through initial public offering
Trading Markets
Saturday, February 12, 2011 - 1:01pm
tags:
AcelRx, pain management
Anacor Pharmaceuticals signs agreement with Medicis Pharmaceutical
Trading Markets
Saturday, February 12, 2011 - 1:00pm
tags:
Anacor, Medicis, acne
49 Days Left - Kahn Swick & Foti, LLC and Former Louisiana Attorney General Remind Investors With Large Financial Interests (Over $100,000) of Lead Plaintiff Deadline in Lawsuit Against MannKind Corp. - MNKD
Yahoo/BusinessWire
Saturday, February 12, 2011 - 12:57pm
tags:
MannKind, lawsuits
Biogen Idec to buy back 20M shares
bizjournals.com
Saturday, February 12, 2011 - 12:56pm
tags:
Biogen Idec
Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BIO CEO and Investor Conference
Yahoo/BusinessWire
Saturday, February 12, 2011 - 12:55pm
tags:
Human Genome Sciences
Biotech Optimists Throw In the Towel
Motley Fool
Saturday, February 12, 2011 - 12:55pm
tags:
biotech, MannKind, Orexigen, Arena Pharmaceuticals, XenoPort, A.P. Pharma
iBio: Risky, But Early Stage Pipeline Potentially Offers Long-Term Reward
Seeking Alpha
Saturday, February 12, 2011 - 12:53pm
tags:
iBio, biosimilars
Axcan completes buyout of Eurand
Yahoo/AP
Saturday, February 12, 2011 - 12:52pm
tags:
Aptalis
Genentech's Lucentis does well in study of diabetic eye condition Read more: Genentech's Lucentis does well in study of diabetic eye condition
bizjournals.com
Saturday, February 12, 2011 - 12:21pm
tags:
Lucentis, Genentech, diabetic macular edema, diabetes
Two ETFs for the Boom in Big Pharma
Seeking Alpha
Saturday, February 12, 2011 - 12:20pm
tags:
Big Pharma
Lilly CEO Criticizes Pace of R&D
Seeking Alpha
Saturday, February 12, 2011 - 12:19pm
tags:
Eli Lilly
Is Pfizer the Right Stock to Retire With?
Motley Fool
Saturday, February 12, 2011 - 12:18pm
tags:
Pfizer
MannKind Shares Plunged: What You Need to Know
Motley Fool
Saturday, February 12, 2011 - 12:18pm
tags:
MannKind, Afrezza, inhaled insulin, diabetes

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.